Joseph Jay Armas, President of Otis Americas, filed a Form 4 on November 4, 2026, disclosing the sale of 835 shares of Otis Worldwide Corp common stock on November 3, 2026.
Dominic Brisby, Chief Executive Officer and Director of Nomad Foods Ltd, filed a Form 4 on November 4, 2026, disclosing a disposition of 70,500 ordinary shares on November 3, 2026, as well as reporting existing derivative security holdings.
Joseph Duxbury, Chief Accounting Officer of Vireo Growth Inc., filed a Form 4 on November 4, 2026, disclosing the acquisition of 63,000 stock options with an exercise price of $7.35 per share, granted on November 3, 2026.
Michael Marinaro, President of Medtronic plc, filed a Form 4 on November 4, 2026, disclosing equity awards granted on November 2, 2026, including restricted stock units, performance share units, and stock options.
Director Michael L. Steiner of Vireo Growth Inc. filed a Form 4 on November 4, 2026, disclosing the acquisition of stock options and restricted stock units on November 3, 2026.
Director Linda T. Hollembaek filed a Form 4 with the SEC on November 4, 2026, reporting the sale of 1,315 shares of Manhattan Associates Inc common stock on November 3, 2026.
Director Rainer Gawlick filed a Form 4 with the SEC on November 4, 2026, disclosing a purchase of Proto Labs Inc common stock on November 3, 2026.
Proto Labs Inc President and CEO Suresh Krishna filed a Form 4 on November 4, 2026, disclosing an open-market purchase of 750 shares of Proto Labs common stock on November 2, 2026.
Jeffrey Bertolini, Chief Operating Officer of Carlsmed, Inc. (NASDAQ:CARL), filed a Form 4 on November 4, 2026, disclosing a stock option exercise and same-day sale of 747 shares of common stock on November 3, 2026.
Jandeen M. Boone, Executive Vice President, General Counsel and Secretary of Ecolab Inc., filed a Form 4 on November 4, 2026, disclosing the vesting of 1,769 restricted stock units on November 2, 2026, and a subsequent withholding of shares to satisfy minimum statutory tax …